Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Adenocarcinoma × Electronic Health Records × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 2 Breast Neoplasms 2 Small Intestinal Neuroendocrine Tumor 1 Pancreatic Adenocarcinoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Heart Failure 1 Cystic Fibrosis 1 Cardiomyopathies 1

Interventions

Gemcitabine 8 Albumin-Bound Paclitaxel 6 Taxes 4 Radiotherapy, Intensity-Modulated 3 130-nm albumin-bound paclitaxel 3 Radiotherapy 2 Fluorouracil 2 niraparib 1 irinotecan sucrosofate 1 folfirinox 1 durvalumab 1 dehydroftorafur 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Resistance Training 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Panitumumab 1 Oxaliplatin 1 Optical Imaging 1 Nivolumab 1 Metformin 1 Losartan 1 Leucovorin 1 Irinotecan 1 Ipilimumab 1 Interleukin 1 Receptor Antagonist Protein 1 Folfox protocol 1 Ethiodized Oil 1 Electronic Health Records 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04406571 2024-01-24

CAPANCOVID-19

CHU de Reims

Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡